Poly-ligand Profiling May Best Predict Response to Trastuzumab Poly-ligand Profiling May Best Predict Response to Trastuzumab

Poly-ligand profiling (PLP), a proprietary technology platform, has the potential to improve patient stratification for trastuzumab by predicting responders more accurately than standard testing, according to a proof-of-concept study.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news